NewGenIvf Group (NASDAQ:NIVF – Get Free Report) was upgraded by analysts at Wall Street Zen to a “hold” rating in a report issued on Saturday.
Separately, Weiss Ratings restated a “sell (d)” rating on shares of NewGenIvf Group in a research note on Friday, October 31st. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, NewGenIvf Group presently has an average rating of “Sell”.
View Our Latest Stock Report on NIVF
NewGenIvf Group Trading Down 2.7%
NewGenIvf Group Company Profile
NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services.
Read More
- Five stocks we like better than NewGenIvf Group
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Rubrik’s Massive Rebound: Why the Next Leg Higher Could Be Fast
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Five Below and Dollar Tree Earnings Signal a Shopper Shift
- Most active stocks: Dollar volume vs share volume
- Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?
Receive News & Ratings for NewGenIvf Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NewGenIvf Group and related companies with MarketBeat.com's FREE daily email newsletter.
